ABS Novacell is a Biopharmaceutical & Biotechnology company with core product development competencies in the following areas :
Novel Vaccines (Viral, Bacterial)-in pipeline
Innovative Bio therapeutics & Biosimilars /Biologics-done research based development on biosimilars.,where USA team have developed Insulin along with analogs with substantial yield improvements cost effectively with cGMP US-FDA standards.
Know MoreOur mission is to become a leading global biopharma company by delivering quality, affordable biologics and biosimilars to alleviate human and animal suffering.
Our vision is to build an innovative biopharmaceutical business in India, leveraging global expertise and novel biologics to emerge as unmatched leaders worldwide.
Vaccines for veterinary and humans to address key diseases affecting animals and people, ensuring effective protection and health safety.
Biological medicine highly similar to an already approved biological reference medicine with no clinically meaningful differences in safety, purity and potency.
Essential tools used for the accurate detection and diagnosis of diseases in clinical and laboratory settings.
Cost-effective pharmaceutical drugs that are therapeutically equivalent to brand-name medicines, providing the same safety and efficacy at a lower price.
Years of Innovation
Global Laboratories
Patents Filed
Global Offices